So far IL-2, IFNα, IFNβ and occasionally IFNγ, IL-6, IL-12 have been the cytokines used for anti-tumor treatment of advanced breast cancer either to induce or increase hormone sensitivity and/or to stimulate cellular immunity. Here, IL6 is linked to breast carcinoma.